2nd Annual NASH Summit 2018

2nd Annual Nonalcoholic Steatohepatitis (NASH) Summit 2018 is organized by Hanson Wade and will be held during Apr 23 - 25, 2018 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America.

Conference Description :
Focused on drug discovery through to late-stage clinical development, the Summit will empower you with the science and connections to accelerate the development of your NASH candidate.

Across multiple streams of learning you’ll hear from 56 industry experts speakers, including Novartis, Gilead, and Allergan, who’ll give detailed presentations on:
• Exploring the scientific rationale and reviewing the latest advances in strategies for effective combination therapies
• Confidently enrolling patients in your clinical trials using multiple biomarkers and non-invasive technologies to diagnose and assess disease regression/progression
• Robustly translating into clinical development by better recapitulating human NASH in vivo

This will provide you with the data, insight, and lessons learned that will enable you to:
• Understand how to progress your candidate towards a combinational NASH treatment and more effectively address this huge unmet medical need
• Define clinical primary and secondary endpoints and understand the status of the biopsy at the time current NASH candidates will enter market to map out your clinical trials
• Utilize metabolomic and inflammatory biomarkers in NASH preclinical development models to more robustly diagnose and track NASH disease progression
• Improve drug efficacy in both early and late stage NASH by identifying and validating novel targets & drug mechanisms of action

Pre-Conference workshops :

Discovery Stream - Workshop A:
Comprehensively Evaluate the Predictions & Understanding of the Microbiome in Nonalcoholic Steatohepatitis.
Reviewing Preclinical Models In-Depth as a Comparison of Traditional & Next Generation Advantages & Disadvantages
Reviewing Preclinical Models In-Depth as a Comparison of Traditional & Next Generation Advantages & Disadvantages

Discovery Stream - Workshop B:
Enhance the Understanding of Liver Cell-to-Cell Interactions in the Pathogenesis of NASH & Evaluate the Opportunity for Next Generation Therapeutic Targets
Exploring the Translatability of Non-Invasive Biomarkers in NASH
Overcoming NASH as the Next Big Global Epidemic & Evaluating the Challenges of Bringing a NASH Drug to Market

Additional details will be posted as soon as they are available.